Present and future projects of the International Breast Cancer Study Group

A. Goldhirsch; R. D. Gelber; M. Castiglione; K. N. Price; C. M. Rudenstam -; J. Lindtner; J. Collins; H. J. Senn; K. W. Brunner; E. Galligioni; F. Cavalli; A. Gudgeon; H. Cortes-Funes; M. Tattersall; G. Marini; M. Byrne; R. Snyder; J. F. Forbes; C. Hurny; A. Coates

Present and future projects of the International Breast Cancer Study Group

A. Goldhirsch, R. D. Gelber, M. Castiglione, K. N. Price, C. M. Rudenstam -, J. Lindtner, J. Collins, H. J. Senn, K. W. Brunner, E. Galligioni, F. Cavalli, A. Gudgeon, H. Cortes-Funes, M. Tattersall, G. Marini, M. Byrne, R. Snyder, J. F. Forbes, C. Hurny, A. Coates

Istituto Europeo di Oncologia

Research output: Contribution to journal › Article › peer-review

Abstract

The International Breast Cancer Study Group (formerly the Ludwig Group) has conducted nine clinical trials since 1978 (see the Appendix for participants and authors). Biologic hypotheses related to the combined use of chemotherapy and endocrine therapy in women with operable breast cancer were tested. Questions of timing of chemotherapy with respect to tumor surgery and late introduction of chemotherapy were also evaluated. On-going and future trials continue in this tradition to investigate combinations of available endocrine therapies and cytotoxic agents.

Original language	English
Pages (from-to)	1139-1149
Number of pages	11
Journal	Cancer
Volume	74
Issue number	3
Publication status	Published - 1994

Keywords

adjuvant therapy
breast cancer
chemoendocrine therapy
chemotherapy
clinical trials
cyclophosphamide-methotrexate-5- fluorouracil
endocrine therapy
tamoxifen

ASJC Scopus subject areas

Cancer Research
Oncology

Fingerprint Dive into the research topics of 'Present and future projects of the International Breast Cancer Study Group'. Together they form a unique fingerprint.

Cite this

Goldhirsch, A., Gelber, R. D., Castiglione, M., Price, K. N., Rudenstam -, C. M., Lindtner, J., Collins, J., Senn, H. J., Brunner, K. W., Galligioni, E., Cavalli, F., Gudgeon, A., Cortes-Funes, H., Tattersall, M., Marini, G., Byrne, M., Snyder, R., Forbes, J. F., Hurny, C., & Coates, A. (1994). Present and future projects of the International Breast Cancer Study Group. Cancer, 74(3), 1139-1149.

Present and future projects of the International Breast Cancer Study Group. / Goldhirsch, A.; Gelber, R. D.; Castiglione, M.; Price, K. N.; Rudenstam -, C. M.; Lindtner, J.; Collins, J.; Senn, H. J.; Brunner, K. W.; Galligioni, E.; Cavalli, F.; Gudgeon, A.; Cortes-Funes, H.; Tattersall, M.; Marini, G.; Byrne, M.; Snyder, R.; Forbes, J. F.; Hurny, C.; Coates, A.

In: Cancer, Vol. 74, No. 3, 1994, p. 1139-1149.

Research output: Contribution to journal › Article › peer-review

Goldhirsch, A, Gelber, RD, Castiglione, M, Price, KN, Rudenstam -, CM, Lindtner, J, Collins, J, Senn, HJ, Brunner, KW, Galligioni, E, Cavalli, F, Gudgeon, A, Cortes-Funes, H, Tattersall, M, Marini, G, Byrne, M, Snyder, R, Forbes, JF, Hurny, C & Coates, A 1994, 'Present and future projects of the International Breast Cancer Study Group', Cancer, vol. 74, no. 3, pp. 1139-1149.

Goldhirsch, A. ; Gelber, R. D. ; Castiglione, M. ; Price, K. N. ; Rudenstam -, C. M. ; Lindtner, J. ; Collins, J. ; Senn, H. J. ; Brunner, K. W. ; Galligioni, E. ; Cavalli, F. ; Gudgeon, A. ; Cortes-Funes, H. ; Tattersall, M. ; Marini, G. ; Byrne, M. ; Snyder, R. ; Forbes, J. F. ; Hurny, C. ; Coates, A. / Present and future projects of the International Breast Cancer Study Group. In: Cancer. 1994 ; Vol. 74, No. 3. pp. 1139-1149.

@article{17dcbeeabffe477a8582a48e36eaf85f,

title = "Present and future projects of the International Breast Cancer Study Group",

abstract = "The International Breast Cancer Study Group (formerly the Ludwig Group) has conducted nine clinical trials since 1978 (see the Appendix for participants and authors). Biologic hypotheses related to the combined use of chemotherapy and endocrine therapy in women with operable breast cancer were tested. Questions of timing of chemotherapy with respect to tumor surgery and late introduction of chemotherapy were also evaluated. On-going and future trials continue in this tradition to investigate combinations of available endocrine therapies and cytotoxic agents.",

keywords = "adjuvant therapy, breast cancer, chemoendocrine therapy, chemotherapy, clinical trials, cyclophosphamide-methotrexate-5- fluorouracil, endocrine therapy, tamoxifen",

author = "A. Goldhirsch and Gelber, {R. D.} and M. Castiglione and Price, {K. N.} and {Rudenstam -}, {C. M.} and J. Lindtner and J. Collins and Senn, {H. J.} and Brunner, {K. W.} and E. Galligioni and F. Cavalli and A. Gudgeon and H. Cortes-Funes and M. Tattersall and G. Marini and M. Byrne and R. Snyder and Forbes, {J. F.} and C. Hurny and A. Coates",

year = "1994",

language = "English",

volume = "74",

pages = "1139--1149",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Present and future projects of the International Breast Cancer Study Group

AU - Goldhirsch, A.

AU - Gelber, R. D.

AU - Castiglione, M.

AU - Price, K. N.

AU - Rudenstam -, C. M.

AU - Lindtner, J.

AU - Collins, J.

AU - Senn, H. J.

AU - Brunner, K. W.

AU - Galligioni, E.

AU - Cavalli, F.

AU - Gudgeon, A.

AU - Cortes-Funes, H.

AU - Tattersall, M.

AU - Marini, G.

AU - Byrne, M.

AU - Snyder, R.

AU - Forbes, J. F.

AU - Hurny, C.

AU - Coates, A.

PY - 1994

Y1 - 1994

N2 - The International Breast Cancer Study Group (formerly the Ludwig Group) has conducted nine clinical trials since 1978 (see the Appendix for participants and authors). Biologic hypotheses related to the combined use of chemotherapy and endocrine therapy in women with operable breast cancer were tested. Questions of timing of chemotherapy with respect to tumor surgery and late introduction of chemotherapy were also evaluated. On-going and future trials continue in this tradition to investigate combinations of available endocrine therapies and cytotoxic agents.

AB - The International Breast Cancer Study Group (formerly the Ludwig Group) has conducted nine clinical trials since 1978 (see the Appendix for participants and authors). Biologic hypotheses related to the combined use of chemotherapy and endocrine therapy in women with operable breast cancer were tested. Questions of timing of chemotherapy with respect to tumor surgery and late introduction of chemotherapy were also evaluated. On-going and future trials continue in this tradition to investigate combinations of available endocrine therapies and cytotoxic agents.

KW - adjuvant therapy

KW - breast cancer

KW - chemoendocrine therapy

KW - chemotherapy

KW - clinical trials

KW - cyclophosphamide-methotrexate-5- fluorouracil

KW - endocrine therapy

KW - tamoxifen

UR - http://www.scopus.com/inward/record.url?scp=0028070089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028070089&partnerID=8YFLogxK

M3 - Article

C2 - 8039150

AN - SCOPUS:0028070089

VL - 74

SP - 1139

EP - 1149

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3

ER -

Present and future projects of the International Breast Cancer Study Group

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Cite this